XTY-24642-81405 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-26
Registered in v-safe
2020-12-26
Dose 1 — Pfizer-BioNTech
2020-12-26
Survey response — day 0, dose 1
MedDRA: Dyspepsia, Gastrooesophageal reflux disease — Feeling: Good

Free text: Mild heart burn/reflux

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-27
Survey response — days 1–6 daily, dose 1
MedDRA: Vision blurred — Feeling: Good · Site: Pain · Fatigue or tiredness

Free text: Blurred vision

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-28
Survey response — days 1–6 daily, dose 1
MedDRA: Vision blurred — Feeling: Good

Free text: Blurred vision -but to a lesser extent than yesterday.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-29
Survey response — days 1–6 daily, dose 1
MedDRA: Vision blurred — Feeling: Good · Fatigue or tiredness

Free text: Blurred vision

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-05
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-09
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-16
Dose 2 — Pfizer-BioNTech
2021-01-16
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · None

Adult check-in
2021-01-17
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Vomiting · Be unable to do your normal daily activities

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-17
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-21
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-25
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-01
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-06
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-22
Call 1 — Left Voicemail
2021-02-27
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-19
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-17
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2022-01-18
Health check-in — 12 months, dose 2
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-26	Pfizer-BioNTech
2	2021-01-16	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-17	Unsuccessful

Free text

Release 1 — day 0, dose 1

2020-12-26

Systemic reaction (other): Mild heart burn/reflux

Release 1 — days 1–6 daily, dose 1

2020-12-27

Systemic reaction (other): Blurred vision

2020-12-28

Systemic reaction (other): Blurred vision -but to a lesser extent than yesterday.

2020-12-29

Systemic reaction (other): Blurred vision

Release 2 — days 1–6 daily, dose 2

2021-01-17

Systemic reaction (other): Dizziness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Dizziness	✓	✓	✓
SRO	Dyspepsia	✓	✓	✓
SRO	Gastrooesophageal reflux disease	✓	✓	✓
SRO	Vision blurred	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release